In February 2024, the Food and Drug Administration (FDA) greenlit the first cellular therapy to treat solid tumors…Thanks to the partnership with Stanford’s Advanced Melanoma Program and Blood and Marrow Transplantation (BMT) & Cellular Therapy Program. Stanford treated the first patient in the world with the approved therapy in April of this year. Click here for the full article